Skip to main content

Joshua D. Fox


[email protected]



Josh advises entrepreneurs to help them build their businesses and complete successful fundraising transactions and exit events.

Josh’s practice focuses on representing founders and start-ups, beginning with the formation of a business entity and continuing through a sale of the company or an IPO. He serves as outside corporate counsel to his clients, functioning as their general counsel throughout the lifecycle of their businesses to help them develop effective legal and business strategies, solve problems, and complete deals that advance their business goals. He regularly advises clients regarding company formation and early-stage legal issues, financings (including angel, venture capital. and strategic investments) and mergers and acquisitions.

Josh typically works with companies in the life sciences industry — drug development, devices, and diagnostics — and in the technology sector, including digital health, software, and technology-enabled services. He has helped numerous clients, including the following, to grow and thrive:  

  • Aquinnah Pharmaceuticals
  • Asimov
  • Axoft
  • Bilayer Therapeutics
  • Droplette
  • Hopewell Therapeutics
  • MediSix Therapeutics
  • NanoView Biosciences
  • NextGen Jane
  • New Equilibrium Biosciences
  • PanTher Therapeutics
  • Quaise Energy
  • Suono Bio
  • Teal Bio

In addition to counseling entrepreneurs and emerging companies, Josh represents investors, including venture capital firms and foundations, in the investments that they make. He frequently speaks on topics related to entrepreneurship, financing, exit strategies, and best practices for businesses, and publishes tips and insights for start-ups.

Josh also maintains an active pro bono practice, is involved in the firm’s hiring activities and is a lecturer at the Boston University School of Law, where he teaches a class on venture capital financings that he created. 


  • Harvard Law School (JD)
  • Tufts University (BA, summa cum laude)

Recognition & Awards

  • Boston Magazine: Top Lawyers – Corporate Law (2021)
  • Conservation Law Foundation, Legal Food Hub: Distinguished Service Award (2019)
  • The Legal 500 United States: Recommended for Finance: Capital Markets: Equity Offerings: Advice to Managers (2016)
  • Boston Magazine: New England Super Lawyers Rising Stars (2008, 2010 – 2016)
  • Boston Bar Association, Lawyers Committee for Civil Rights Under Law: Civil Rights Recognition Award (2010)
  • Phi Beta Kappa


  • Past Member, Board of Visitors, D’Amore-McKim School of Business, Northeastern University
  • Past President and Member, Board of Directors, Tufts Lawyers Association
  • Past Mentor, BUILD
  • Past Member, Leadership Council, Dana-Farber Cancer Institute
  • Past Member, Alumni Council, Tufts University

Recent Insights

News & Press



Life Sciences M&A Report June 2020

BAND TOGETHER: Corporate & Cultural Convergence in Life Sciences M&A

June 24, 2020 | | By William Whelan, Joshua D. Fox

The Mintz and Mergermarket report on recent M&A activity in the life sciences sector examines deal drivers and companies’ post-closing integration experiences.
Read more

News & Press

Press Release Thumbnail
Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.
Press Release Thumbnail
In New Report, Dealmakers across the Life Sciences Industry Identify Top Deal Drivers, Successful Integration Strategies, and More.
An article published by The American Lawyer highlighted the arrival of Joshua Fox in Boston and Stephen Osborn in San Francisco as Members in Mintz’s Corporate group.

The article noted that “Osborn and Fox are the latest hires in Mintz’s growing corporate practice, which also had two notable hires in March. The Boston-based firm is enjoying record revenue and profit highs after four straight years of growth.”


Guest Lecturer
Webinar Reference Image